Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1957 2
1961 1
1962 1
1963 6
1964 11
1965 2
1966 11
1967 3
1968 3
1969 5
1970 6
1971 14
1972 10
1973 8
1974 9
1975 8
1976 6
1977 9
1978 6
1979 9
1980 11
1981 15
1982 13
1983 18
1984 23
1985 26
1986 24
1987 25
1988 36
1989 45
1990 43
1991 39
1992 43
1993 54
1994 39
1995 56
1996 58
1997 57
1998 61
1999 61
2000 62
2001 76
2002 89
2003 89
2004 88
2005 88
2006 116
2007 118
2008 106
2009 111
2010 125
2011 102
2012 135
2013 143
2014 159
2015 151
2016 152
2017 196
2018 222
2019 212
2020 247
2021 258
2022 271
2023 218
2024 94

Text availability

Article attribute

Article type

Publication date

Search Results

4,063 results

Results by year

Filters applied: . Clear all
Page 1
J-AVENUE: A retrospective, real-world study evaluating patient characteristics and outcomes in patients with advanced urothelial carcinoma treated with avelumab first-line maintenance therapy in Japan.
Kikuchi E, Hayakawa N, Nakayama M, Uno M, Nakatsu H, Kitagawa C, Miyake H, Yamada T, Fujita K, Shimoyama H, Nishihara K, Kobayashi M, Nakamura M, Fujimoto K, Sano T, Nishiyama N, Ito T, Kajita M, Kobayashi T, Kitamura H. Kikuchi E, et al. Among authors: fujimoto k. Int J Urol. 2024 May 9. doi: 10.1111/iju.15473. Online ahead of print. Int J Urol. 2024. PMID: 38722221
In vitro and in vivo activities of KSP-1007, a broad-spectrum inhibitor of serine- and metallo-β-lactamases, in combination with meropenem against carbapenem-resistant Gram-negative bacteria.
Takemoto K, Nakayama R, Fujimoto K, Suzuki Y, Takarabe Y, Honsho M, Kitahara S, Noguchi Y, Matsui H, Hirose T, Asami Y, Hidaka J, Sunazuka T, Hanaki H. Takemoto K, et al. Among authors: fujimoto k. Antimicrob Agents Chemother. 2024 May 6:e0160223. doi: 10.1128/aac.01602-23. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 38709005
Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
Kawai T, Matsuyama H, Kobayashi K, Ikeda A, Miyake M, Nishimoto K, Matsushita Y, Nishiyama H, Fujimoto K, Oyama M, Miyake H, Azuma H, Inoue K, Mitsui T, Kawakita M, Oyama C, Mizokami A, Abe T, Kuroiwa H, Kume H. Kawai T, et al. Among authors: fujimoto k. Int J Urol. 2024 May 2. doi: 10.1111/iju.15483. Online ahead of print. Int J Urol. 2024. PMID: 38695571
Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
Miyake M, Nishimura N, Nakahama T, Nishimoto K, Oyama M, Matsushita Y, Miyake H, Fukuhara H, Inoue K, Kobayashi K, Matsuyama H, Fujii T, Hirao Y, Fujimoto K. Miyake M, et al. Among authors: fujimoto k. Int J Urol. 2024 Apr 30. doi: 10.1111/iju.15474. Online ahead of print. Int J Urol. 2024. PMID: 38687165
Author Correction: Resting‑state functional magnetic resonance imaging indices are related to electrophysiological dysfunction in degenerative cervical myelopathy.
Akimoto H, Suzuki H, Kan S, Funaba M, Nishida N, Fujimoto K, Ikeda H, Yonezawa T, Ikushima K, Shimizu Y, Matsubara T, Harada K, Nakagawa S, Sakai T. Akimoto H, et al. Among authors: fujimoto k. Sci Rep. 2024 Apr 25;14(1):9524. doi: 10.1038/s41598-024-60360-8. Sci Rep. 2024. PMID: 38664525 Free PMC article. No abstract available.
4,063 results